CDH5 and central nervous system cancer: Recently, it was demonstrated that inhibition of IGFBP2 in U251 cells in an orthotopic mouse model significantly reduces angiogenesis mimic formation and inhibition of tumor progression, and IGFBP2 stimulates glioma cell angiogenic mimicry formation via CD144 and MMP2 up-regulation [5].